I am a
Home I AM A Search Login

Papers of the Week

2022 Jun 10

JMIR Form Res



Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study.


Vosburg SK, Dailey-Govoni T, Beaumont J, Butler SF, Green JL
JMIR Form Res. 2022 Jun 10; 6(6):e16996.
PMID: 35687397.


The prevalence of abuse, diversion, and web-based endorsement of tapentadol (extended-release [ER], immediate-release [IR]) has been characterized as low compared with other prescription opioids. Little is known about individual experience with tapentadol nonmedical use (NMU).